Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/120662
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRies, Jutta-
dc.contributor.authorAgaimy, Abbas-
dc.contributor.authorWehrhan, Falk-
dc.contributor.authorBaran, Christoph Adam-
dc.contributor.authorBolze, Stella-
dc.contributor.authorDanzer, Eva-
dc.contributor.authorFrey, Silke-
dc.contributor.authorJantsch, Jonathan-
dc.contributor.authorMöst, Tobias-
dc.contributor.authorBüttner-Herold, Maike-
dc.contributor.authorWickenhauser, Claudia-
dc.contributor.authorKesting, Marco-
dc.contributor.authorWeber, Manuel-
dc.date.accessioned2025-10-01T09:24:17Z-
dc.date.available2025-10-01T09:24:17Z-
dc.date.issued2021-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/122617-
dc.identifier.urihttp://dx.doi.org/10.25673/120662-
dc.description.abstractThe programmed cell death ligand 1/programmed cell death receptor 1 (PD-L1/PD-1) Immune Checkpoint is an important modulator of the immune response. Overexpression of the receptor and its ligands is involved in immunosuppression and the failure of an immune response against tumor cells. PD-1/PD-L1 overexpression in oral squamous cell carcinoma (OSCC) compared to healthy oral mucosa (NOM) has already been demonstrated. However, little is known about its expression in oral precancerous lesions like oral leukoplakia (OLP). The aim of the study was to investigate whether an increased expression of PD-1/PD-L1 already exists in OLP and whether it is associated with malignant transformation.-
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc610-
dc.titleImportance of the PD-1/PD-L1 axis for malignant transformation and risk assessment of oral leukoplakiaeng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleBiomedicines-
local.bibliographicCitation.volume9-
local.bibliographicCitation.issue2-
local.bibliographicCitation.publishernameMDPI-
local.bibliographicCitation.publisherplaceBasel-
local.bibliographicCitation.doi10.3390/biomedicines9020194-
local.openaccesstrue-
dc.identifier.ppn1845278356-
cbs.publication.displayform2021-
local.bibliographicCitation.year2021-
cbs.sru.importDate2025-10-01T09:22:04Z-
local.bibliographicCitationEnthalten in Biomedicines - Basel : MDPI, 2013-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
biomedicines-09-00194-v2.pdf19.83 MBAdobe PDFThumbnail
View/Open